ENGN insider buying
Every open-market purchase of enGene Therapeutics Inc. (ENGN) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$10.05K
Insiders buying (12m)1
Purchases on record1
Last purchase filedSep 24, 2026
In the last 12 months, 1 insider of enGene Therapeutics Inc. bought $10.05K of ENGN stock on the open market in 1 reported purchase. The most recent was filed on Sep 24, 2026: Grossman William (Interim Chief Medical Officer, Director) bought 5,102 shares at $1.97, worth $10.05K.
Get the next ENGN insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll ENGN insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Sep 24 | Grossman WilliamInterim Chief Medical Officer, Di… | $10.05K | 5,102 | $1.97 | new | Sep 22 | SEC |